Back

Malnutrition, frailty, and physical performance in transthyretin cardiac amyloidosis: insights from a prospective multicenter cohort study

17 May 2025 (15:15 - 15:30)
Organised by: Logo
Congress Presentation Part of: Cardiac amyloidosis uncovered: from clues to cutting-edge care Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Carlo Fumagalli

University of Campania Luigi Vanvitell, Naples (Italy)

2 More presentations in this session

Presentation thumbnail
Cardiac resynchronization therapy, remodeling and outcome in patients with amyloid transthyretin cardiomyopathy
Doctor A. Aimo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidis
Professor M. Merlo (Trieste, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac amyloidosis uncovered: from clues to cutting-edge care
Video

The Event

Event poster

Heart Failure 2025

17 May 2025 15:15 CET
You may be interested in
thumbnail
Congress Session
Transthyretin cardiac amyloidosis
thumbnail
Congress Session
Cardiac amyloidosis from epidemiology to treatment
thumbnail
Congress Presentation
Multiparametric assessment of frailty in transthyretin amyloidosis cardiomyopathy and its correlation with prognostic staying scores.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources